Cargando…
Spinal fluid IgG antibodies from patients with demyelinating diseases bind multiple sclerosis-associated bacteria
ABSTRACT: A panel of 10 IgG enzyme-linked immunosorbent assays (ELISAs) were developed for the detection of anti-microbial immune responses in the cerebrospinal fluid (CSF) of patients with demyelinating diseases (DD). The anti-microbial ELISA assays follow on prior human brain tissue RNA sequencing...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185491/ https://www.ncbi.nlm.nih.gov/pubmed/34100959 http://dx.doi.org/10.1007/s00109-021-02085-z |
_version_ | 1783704798529323008 |
---|---|
author | Eckman, Emily Laman, Jon D. Fischer, Kael F. Lopansri, Bert Martins, Tom B. Hill, Harry R. Kriesel, John D. |
author_facet | Eckman, Emily Laman, Jon D. Fischer, Kael F. Lopansri, Bert Martins, Tom B. Hill, Harry R. Kriesel, John D. |
author_sort | Eckman, Emily |
collection | PubMed |
description | ABSTRACT: A panel of 10 IgG enzyme-linked immunosorbent assays (ELISAs) were developed for the detection of anti-microbial immune responses in the cerebrospinal fluid (CSF) of patients with demyelinating diseases (DD). The anti-microbial ELISA assays follow on prior human brain tissue RNA sequencing studies that established multiple sclerosis (MS) microbial candidates. Lysates included in the ELISA panel were derived from Akkermansia muciniphila, Atopobium vaginae, Bacteroides fragilis, Lactobacillus paracasei, Odoribacter splanchnicus, Pseudomonas aeruginosa, Cutibacterium (Propionibacterium) acnes, Fusobacterium necrophorum, Porphyromonas gingivalis, and Streptococcus mutans. CSF responses from patients with demyelinating diseases (DD, N = 14) were compared to those with other neurological diseases (OND, N = 8) and controls (N = 13). Commercial positive and negative control CSF specimens were run with each assay. ELISA index values were derived for each specimen against each of the 10 bacterial lysates. CSF reactivity was significantly higher in the DD group compared to the controls against Akkermansia, Atopobium, Bacteroides, Lactobacillus, Odoribacter, and Fusobacterium. Four of the 11 tested DD group subjects had elevated antibody indexes against at least one of the 10 bacterial species, suggesting intrathecal antibody production. This CSF serological study supports the hypothesis that several of the previously identified MS candidate microbes contribute to demyelination in some patients. KEY MESSAGES: A panel of 10 IgG enzyme-linked immunosorbent assays (ELISAs) were developed for the detection of anti-microbial immune responses in the cerebrospinal fluid (CSF) of patients with demyelinating diseases, including multiple sclerosis and acute disseminated encephalomyelitis. CSF reactivity was significantly higher in the demyelination group compared to the controls against the bacteria Akkermansia, Atopobium, Bacteroides, Lactobacillus, Odoribacter, and Fusobacterium. Several of the demyelination subjects had elevated antibody indexes against at least one of the 10 antigens, suggesting at least limited intrathecal production of anti-bacterial antibodies. This CSF serological study supports the hypothesis that several of the previously identified MS candidate microbes contribute to demyelination in some patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00109-021-02085-z. |
format | Online Article Text |
id | pubmed-8185491 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-81854912021-06-08 Spinal fluid IgG antibodies from patients with demyelinating diseases bind multiple sclerosis-associated bacteria Eckman, Emily Laman, Jon D. Fischer, Kael F. Lopansri, Bert Martins, Tom B. Hill, Harry R. Kriesel, John D. J Mol Med (Berl) Original Article ABSTRACT: A panel of 10 IgG enzyme-linked immunosorbent assays (ELISAs) were developed for the detection of anti-microbial immune responses in the cerebrospinal fluid (CSF) of patients with demyelinating diseases (DD). The anti-microbial ELISA assays follow on prior human brain tissue RNA sequencing studies that established multiple sclerosis (MS) microbial candidates. Lysates included in the ELISA panel were derived from Akkermansia muciniphila, Atopobium vaginae, Bacteroides fragilis, Lactobacillus paracasei, Odoribacter splanchnicus, Pseudomonas aeruginosa, Cutibacterium (Propionibacterium) acnes, Fusobacterium necrophorum, Porphyromonas gingivalis, and Streptococcus mutans. CSF responses from patients with demyelinating diseases (DD, N = 14) were compared to those with other neurological diseases (OND, N = 8) and controls (N = 13). Commercial positive and negative control CSF specimens were run with each assay. ELISA index values were derived for each specimen against each of the 10 bacterial lysates. CSF reactivity was significantly higher in the DD group compared to the controls against Akkermansia, Atopobium, Bacteroides, Lactobacillus, Odoribacter, and Fusobacterium. Four of the 11 tested DD group subjects had elevated antibody indexes against at least one of the 10 bacterial species, suggesting intrathecal antibody production. This CSF serological study supports the hypothesis that several of the previously identified MS candidate microbes contribute to demyelination in some patients. KEY MESSAGES: A panel of 10 IgG enzyme-linked immunosorbent assays (ELISAs) were developed for the detection of anti-microbial immune responses in the cerebrospinal fluid (CSF) of patients with demyelinating diseases, including multiple sclerosis and acute disseminated encephalomyelitis. CSF reactivity was significantly higher in the demyelination group compared to the controls against the bacteria Akkermansia, Atopobium, Bacteroides, Lactobacillus, Odoribacter, and Fusobacterium. Several of the demyelination subjects had elevated antibody indexes against at least one of the 10 antigens, suggesting at least limited intrathecal production of anti-bacterial antibodies. This CSF serological study supports the hypothesis that several of the previously identified MS candidate microbes contribute to demyelination in some patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00109-021-02085-z. Springer Berlin Heidelberg 2021-06-08 2021 /pmc/articles/PMC8185491/ /pubmed/34100959 http://dx.doi.org/10.1007/s00109-021-02085-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Eckman, Emily Laman, Jon D. Fischer, Kael F. Lopansri, Bert Martins, Tom B. Hill, Harry R. Kriesel, John D. Spinal fluid IgG antibodies from patients with demyelinating diseases bind multiple sclerosis-associated bacteria |
title | Spinal fluid IgG antibodies from patients with demyelinating diseases bind multiple sclerosis-associated bacteria |
title_full | Spinal fluid IgG antibodies from patients with demyelinating diseases bind multiple sclerosis-associated bacteria |
title_fullStr | Spinal fluid IgG antibodies from patients with demyelinating diseases bind multiple sclerosis-associated bacteria |
title_full_unstemmed | Spinal fluid IgG antibodies from patients with demyelinating diseases bind multiple sclerosis-associated bacteria |
title_short | Spinal fluid IgG antibodies from patients with demyelinating diseases bind multiple sclerosis-associated bacteria |
title_sort | spinal fluid igg antibodies from patients with demyelinating diseases bind multiple sclerosis-associated bacteria |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185491/ https://www.ncbi.nlm.nih.gov/pubmed/34100959 http://dx.doi.org/10.1007/s00109-021-02085-z |
work_keys_str_mv | AT eckmanemily spinalfluidiggantibodiesfrompatientswithdemyelinatingdiseasesbindmultiplesclerosisassociatedbacteria AT lamanjond spinalfluidiggantibodiesfrompatientswithdemyelinatingdiseasesbindmultiplesclerosisassociatedbacteria AT fischerkaelf spinalfluidiggantibodiesfrompatientswithdemyelinatingdiseasesbindmultiplesclerosisassociatedbacteria AT lopansribert spinalfluidiggantibodiesfrompatientswithdemyelinatingdiseasesbindmultiplesclerosisassociatedbacteria AT martinstomb spinalfluidiggantibodiesfrompatientswithdemyelinatingdiseasesbindmultiplesclerosisassociatedbacteria AT hillharryr spinalfluidiggantibodiesfrompatientswithdemyelinatingdiseasesbindmultiplesclerosisassociatedbacteria AT krieseljohnd spinalfluidiggantibodiesfrompatientswithdemyelinatingdiseasesbindmultiplesclerosisassociatedbacteria |